Tag Archives: Amylin Pharmaceuticals

Defective/Dangerous Drug Litigation Heating Up in Southern California Courthouse

A class of diabetes drugs linked to pancreatic cancer and serious or fatal forms of pancreatitis has led to a massive litigation in a southern California courtroom. Several hundred cases have been filed against drug makers Merck & Co. (Merck Sharp & Dohme Corp.), Eli Lilly and Company, Novo Nordisk, Inc. and Amylin Pharmaceuticals…. Read More »